Biktarvy, formally known as bictegravir sulfate, represents a effective single-tablet therapy for treating HIV infection. This formula combines three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the HIV's ability to multiply within the body, remarkably reducing the viral quantity. For m